IPI-145 (Duvelisib, INK1197)
目录号: A12422
PI3K-δ/PI3K-γ 抑制剂
IPI-145,亦称为 INK-1197,是一种口服生物利用度高、选择性强且效力高的小分子抑制剂,针对磷脂酰肌醇-3激酶(PI3K)的 delta 和 gamma 亚型,具有潜在的免疫调节和抗肿瘤活性。
Discription | IPI-145, also known as INK-1197, is an orally bioavailable, highly selective and potent small molecule inhibitor of the delta and gamma isoforms of phosphoinositide-3 kinase (PI3K) with potential immunomodulating and antineoplastic activities. | |||||
---|---|---|---|---|---|---|
Targets |
|
|||||
Cell Research |
|
目录号 | A12422 |
---|---|
分子式 | C22H17ClN6O |
分子量 | 416.86 |
CAS号 | 1201438-56-3 |
SMILES | C[C@@H](C1=CC2=C(C(=CC=C2)Cl)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5 |
其他名称 | IPI145; IPI 145; IPI-145. INK-1197; INK 1197; INK1197 |
储存条件 | Store lyophilized at -20ºC, keep desiccated. |
In vitro (25°C) | DMSO | 76 mg/mL (182.31 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
In vivo | 30% PEG400+0.5% Tween80+5% propylene glycol | 28 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 23.99 mL | 119.94 mL | 239.89 mL |
0.5 mM | 4.8 mL | 23.99 mL | 47.98 mL |
1 mM | 2.4 mL | 11.99 mL | 23.99 mL |
5 mM | 0.48 mL | 2.4 mL | 4.8 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2